05.08.2011 • News

Huntsman Q2 Adjusted Profit Up

Huntsman posted second-quarter net income attributable to the company of $114 million or $0.47 per share, flat with last year. Adjusted net income for the second quarter rose to $117 million or $0.48 per share from $75 million or $0.31 per share in the year-ago quarter.

Analysts polled by Thomson Reuters expected the company to earn $0.49 per share in the quarter. Analysts' estimates typically exclude special items.

Revenues were $2.93 billion versus $2.34 billion last year. The Street estimated revenues of $2.77 billion for the quarter.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read